| 분자 | Cat. No. | Product Name | 종 | Host | 구조 | 순도 | Activity | 규격 및 가격 |
|---|---|---|---|---|---|---|---|---|
| Cathepsin B | Human Cathepsin B / CTSB (L26V) Protein, Tag Free (Pro-form, MALS verified) | Human | HEK293 | ![]() | MALSSDS-PAGE | $367.00 50ug | ||
| Cathepsin B | Human Cathepsin B / CTSB Protein, His Tag (Pro-form, Mass Spec & MALS verified) | Human | HEK293 | ![]() | MALSSDS-PAGE | $400.00 50ug | ||
| Cathepsin B | Human Cathepsin B / CTSB (18-339) Protein, His Tag (Pro-form, MALS verified) | Human | HEK293 | ![]() | MALSSDS-PAGE | $367.00 50ug | ||
| Cathepsin B | Mouse Cathepsin B / CTSB Protein, His Tag (Pro-form, MALS verified) | Mouse | HEK293 | ![]() | MALSSDS-PAGE | $350.00 50ug |
| 영어 이름 | 연구 코드 | 연구 개발 단계 | 회사 | 적응증 | 임상 시험 |
|---|---|---|---|---|---|
| Osugacestat | AL-101(BMS); BMS-906024; BM-0018 | Phase 2 Clinical | Bristol-Myers Squibb Company, Glaxosmithkline Plc | Carcinoma, Adenoid Cystic; Neoplasms; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Triple Negative Breast Neoplasms | 상세 |
| cysteine protease inhibitor (Boehringer Ingelheim) | Phase 1 Clinical | Boehringer Ingelheim International Gmbh | Respiratory Tract Diseases | 상세 |
